← All trials
NCT06265727
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2024
- Primary completion
- Jan 16, 2027
- Completion date
- Jan 27, 2027
- First posted
- Feb 20, 2024
- Last posted
- Aug 20, 2024
- Enrollment
- 420
- Arms / groups
- 11 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Corbus Pharmaceuticals Inc.Lead sponsor
- University of ChicagoOfficial
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Collaborator
- Imperial College LondonOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.